Earnings History Data for Checkpoint Therapeutics, Inc. (CKPT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10-05-2024 | PM | CKPT | Checkpoint Therapeutics | 58.00 | -0.33 | -0.37 | 0.00 | Checkpoint Therapeutics GAAP EPS of -$0.33 [5/10/2024 9:46 AM] |
1.49 | -0.07 (-4.26%) |
1.57 | 0.01 (0.64%) |
1.30 - 3.62 | 934,045 | 330,000 | 6,020 | ||
22-03-2024 | PM | CKPT | Checkpoint Therapeutics | 44.00 | -1.10 | -0.74 | 0.00 | Checkpoint Therapeutics GAAP EPS of -$3.17 misses by $0.49, revenue of $0.1M misses by $0.02M [3/22/2024 9:05 AM] |
1.92 | 0.02 (1.05%) |
1.94 | 0.04 (2.11%) |
1.30 - 4.29 | 475,010 | 350,000 | 2,586 | ||
15-05-2023 | AH | CKPT | Checkpoint Therapeutics | 36.00 | -0.89 | -0.92 | 0.00 | Checkpoint Therapeutics GAAP EPS of -$0.89 [5/15/2023 4:58 PM] |
2.78 | -0.05 (-1.77%) |
2.88 | 0.05 (1.77%) |
1.84 - 14.90 | 298,973 | 210,000 | 3,772 | ||
08-11-2022 | AH | After the close (Nov 8) |
CKPT | Checkpoint Therapeutics | 84.00 | -0.12 | -0.17 | 0.00 | Checkpoint Therapeutics GAAP EPS of -$0.12 beats by $0.03, revenue of $0.05M [11/8/2022 5:10 PM] |
0.6898 | -0.03 (-3.65%) |
0.75 | 0.03 (4.76%) |
0.50 - 4.54 | 559,965 | 450,000 | 1,355 | |
12-08-2022 | PM | CKPT | Checkpoint Therapeutics, Inc. | 107.41 | -0.16 | -0.17 | -0.12 | Checkpoint Therapeutics GAAP EPS of -$0.16 in-line, revenue of $0.02M beats by $0.01M [8/12/2022 8:25 AM] |
1.29 | 0.03 (2.38%) |
1.23 | -0.03 (-2.38%) |
0.96 - 4.64 | 260,107 | 470,000 | 18,599 | ||
28-03-2022 | PM | Before the open (Mar 28) |
CKPT | Checkpoint Therapeutics | 158.00 | -0.39 | -0.14 | 0.00 | Checkpoint Therapeutics GAAP EPS of -$0.75 misses by $0.24, revenue of $0.27M misses by $0.09M [3/28/2022 8:03 AM] |
1.72 | -0.06 (-3.37%) |
1.73 | -0.05 (-2.80%) |
1.49 - 4.64 | 792,437 | 700,000 | 3,751 | |
04-11-2021 | AH | 4:30 PM ET (Nov 4) |
CKPT | Checkpoint Therapeutics, Inc. | 312.76 | -0.14 | -0.13 | -0.09 | Checkpoint Therapeutics EPS in-line, misses on revenue [11/4/2021 5:30 PM] |
4.24 | 0.04 (0.83%) |
4.00 | -0.21 (-4.99%) |
2.20 - 5.38 | 975,673 | 1,050,000 | 16,405 | |
05-08-2021 | AH | CKPT | Checkpoint Therapeutics, Inc. | 213.00 | -0.12 | -0.09 | -0.09 | Checkpoint Therapeutics EPS misses by $0.02, beats on revenue [8/5/2021 5:26 PM] |
2.60 | 0.05 (1.96%) |
2.57 | 0.02 (0.78%) |
1.90 - 5.38 | 572,748 | 660,000 | 20,233 | ||
06-05-2021 | AH | CKPT | Checkpoint Therapeutics, Inc. | 218.12 | -0.09 | -0.13 | -0.06 | Checkpoint Therapeutics EPS beats by $0.01, misses on revenue [5/6/2021 5:24 PM] |
2.52 | 0.16 (6.78%) |
2.48 | 0.12 (5.08%) |
1.56 - 5.38 | 1,770,923 | 930,000 | 6,957 | ||
09-03-2021 | AH | CKPT | Checkpoint Therapeutics, Inc. | 225.00 | -0.17 | -0.08 | 0.00 | Checkpoint Therapeutics EPS misses by $0.09, misses on revenue [3/9/2021 4:37 PM] |
3.22 | 0.03 (0.94%) |
3.22 | 0.03 (0.94%) |
1.05 - 5.38 | 4,553,483 | 1,398,785 | 2,748 | ||
04-11-2020 | PM | CKPT | Checkpoint Therapeutics, Inc. | 136.00 | -0.09 | -0.08 | 0.00 | 0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |||
|
||||||||||||||||||
04-11-2020 | AH | CKPT | Checkpoint Therapeutics, Inc. | 161.36 | -0.09 | -0.08 | -0.15 | Checkpoint Therapeutics EPS misses by $0.01, misses on revenue [11/4/2020 4:42 PM] |
2.44 | 0.10 (4.49%) |
2.30 | -0.04 (-1.71%) |
1.05 - 4.50 | 188,089 | 323,366 | 660 | ||
|